http://orcid.org/0000-0003-3064-8564
References
- Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci. 2011;108(Suppl 1):4680–4687.
- Bing M, Forney L, Ravel J. The vaginal microbiome: rethinking health and disease. Ann Rev Microbiol. 2012;66:371–389.
- Gaydos CA, Beqaj S, Schwebke JR, et al. Clinical validation of a test for the diagnosis of vaginitis. Obstet Gynecol. 2017;130:181–189.
- Schwebke JR, Gaydos CA, Nyirjesy P, et al. Diagnostic performance of a molecular test versus clinician assessment of vaginitis. J Clin Microbiol. 2018;56: on-line Ahead of Print.
- Pheifer TA, Forsyth PS, Durfee MA, et al. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med. 1978;298:1429–1434.
- Arya OP, Tong CYW, Hart CA, et al. Is mycoplasma hominis a vaginal pathogen? Sex Transm Infect. 2001;77:58–62.
- Rodrigues MM, Fernandes PA, Haddad JP, et al. Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. J Obstet Gynaecol. 2011;31:237–241.
- Horner P, Donders G, Cusini M, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and U. urealyticum in men and women?–a position statement from the European STI guidelines editorial board. J Eur Acad Dermatol Venereol. 2018; 1-7.
- Choe HS, Lee DS, Lee SJ, et al. Performance of Anyplex II multiplex real-time PCR for the diagnosis of seven sexually transmitted infections: comparison with currently available methods. Int J Infect Dis. 2013;17:e1134–40.
- Brosh-Nissimov T, Kedem R, Ophir N, et al. Management of sexually transmissible infections in the era of multiplexed molecular diagnostics: a primary care survey. Sex Health. 2018;15:298–303.
- Ison CA, Fifer H, Gwynn S, et al. Highlighting the clinical need for diagnosing Mycoplasma genitalium infection. Int J STD AIDS. 2018;29:680–686.
- Xiao L, Waites KB, Wang H, et al. Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens. Diagn Microbiol Infect Dis. 2018;91:123–125.
- Unemo M, Salado-Rasmussen K, Hansen M, et al. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clini Microbiol Infect. 2018;24:533–539.
- Tabrizi SN, Tan LY, Walker S, et al. Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexZyme and PlexPrime technology. PLoS One. 2016;11:e0156740.
- Balkus JE, Manhart LE, Jensen JS, et al. Mycoplasma genitalium infection in Kenyan and US women. Sex Transm Dis. 2018;45:514–521.